Replies to post #971 on Cardiff Oncology, Inc. (CRDF)

[Full Contact Yoga]

Could be, worth watching. Lost 88% on the year, facing delisting and RS, but might have some approvals...with approvals, $4ish seems doable, need to act quick though. 1st extension for RS in early March, should buy another 6 months to sink or swim IMO.